Genvinset® deltaF508

CE IVD real-time PCR kit for detection of genetic polymorphisms and mutations in human genomic DNA using fluorescently labelled probes. Enables genotyping of pharmacogenetic variants including CYP2C19, TPMT, UGT1A1, and alpha-1 antitrypsin mutations for personalized medicine applications.

An NGS solution kit for detection of SNP and indels in the CFTR gene causing Cystic Fibrosis disease. The kit utilizes lyophilized library preparation reagents with simplified one-tube protocol and integrates with V-Xplora software for efficient analysis and interpretation of genetic variants.

PCR-based detection kit for identifying cystic fibrosis transmembrane conductance regulator mutations in patient samples. Enables genetic screening for cystic fibrosis susceptibility and diagnosis.

CE IVD certified genetic testing kits for diagnostic and screening purposes across multiple genetic conditions. Meets European regulatory requirements for in vitro diagnostic medical devices.

A diagnostic test kit for the detection of SARS-CoV-2 using EvaGreen technology.

Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.

Diagnostic system for genetic analysis and hereditary condition screening. Utilizes molecular techniques for identification of genetic markers and chromosomal abnormalities.

In-vitro diagnostic tests for genetic analysis and disease risk assessment. These tests utilize molecular techniques to identify genetic variations and mutations relevant to clinical diagnosis and patient stratification. Designed for laboratory use in healthcare facilities and diagnostic centers.

CE IVD real-time PCR kit for detection of NUDT15 R139C polymorphism in human genomic DNA. Enables pharmacogenetic genotyping to guide personalized drug dosing and treatment selection. Uses fluorescently labeled probes for allelic discrimination with qPCR analysis.

Molecular in vitro diagnostic solution for detection of serious infections and genetic diseases. Provides automated sample-to-result analysis with flexible testing protocols for clinical laboratory use.

A registered laboratory diagnostic test kit enabling qualitative detection of SARS-CoV-2 RNA directly from patient saliva samples using isothermal RT-LAMP amplification with simplified sample preparation. The kit provides rapid results within tens of minutes from sample receipt, increases patient comfort by eliminating nasopharyngeal swab procedures, and reduces exposure risk for sampling personnel while requiring no specialized technical skills. It is approved for sale in the European Union.